Sotac Pharmaceuticals Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -117.00 0.00 (0.00%)Updated : 17 Apr 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 124.33 | 105.33 | 54.78 | 35.25 |
| Accumulated Depreciation Total | -13.89 | - | - | -4.74 |
| Cash Equivalents | 0.55 | 3.42 | 9.60 | - |
| Other Liabilities Total | 0.16 | 0.14 | 9.56 | 0.06 |
| Accrued Expenses | 0.25 | - | - | - |
| Long Term Debt | 14.19 | 12.13 | 6.59 | 0.97 |
| Common Stock Total | 11.05 | 11.05 | 8.05 | 2.30 |
| Other Equity Total | 0.27 | - | - | - |
| Other Current Assets Total | 2.25 | 12.76 | 5.92 | 5.53 |
| Prepaid Expenses | 0.22 | - | - | - |
| Total Assets | 124.33 | 105.33 | 54.78 | 35.25 |
| Current Portof LT Debt/ Capital Leases | 10.75 | 2.85 | - | - |
| Additional Paid- In Capital | 28.02 | - | - | - |
| Cash | 1.01 | - | - | 0.03 |
| Total Equity | 53.25 | 45.26 | 11.52 | 6.62 |
| Long Term Investments | 3.78 | 2.10 | 4.00 | 0.39 |
| Retained Earnings( Accumulated Deficit) | 13.91 | 34.21 | 3.47 | 4.32 |
| Total Common Shares Outstanding | 1.11 | 1.11 | 0.81 | 1.11 |
| Property/ Plant/ Equipment Total- Gross | 60.64 | - | - | 13.53 |
| Tangible Book Valueper Share Common Eq | 46.45 | 39.23 | 14.31 | 5.99 |
| Goodwill Net | 1.90 | 1.90 | - | - |
| Total Liabilities | 71.08 | 60.07 | 43.26 | 28.63 |
| Total Debt | 43.70 | 24.86 | 10.66 | 7.39 |
| Short Term Investments | 0.69 | - | - | 0.00 |
| Cashand Short Term Investments | 2.25 | 3.42 | 9.60 | 0.03 |
| Total Receivables Net | 44.13 | 26.46 | 11.51 | 14.92 |
| Notes Payable/ Short Term Debt | 18.75 | 9.88 | 4.06 | 6.42 |
| Accounts Receivable- Trade Net | 34.11 | 26.29 | 11.50 | 12.25 |
| Property/ Plant/ Equipment Total- Net | 46.77 | 33.60 | 14.09 | 8.79 |
| Minority Interest | 5.17 | 4.07 | - | - |
| Total Current Liabilities | 51.55 | 43.73 | 27.11 | 27.61 |
| Total Inventory | 20.98 | 18.01 | 9.58 | 5.39 |
| Accounts Payable | 18.94 | 28.89 | 18.20 | 19.74 |
| Other Currentliabilities Total | 2.85 | 2.11 | 4.85 | 1.45 |
| Total Long Term Debt | 14.19 | 12.13 | 6.59 | 0.97 |
| Intangibles Net | 0.02 | 0.01 | 0.00 | 0.01 |
| Other Long Term Assets Total | 2.03 | 6.55 | 0.08 | 0.02 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 69.83 | 60.65 | 36.61 | 25.88 |
| Note Receivable- Long Term | - | 0.53 | - | 0.16 |
| Deferred Income Tax | - | - | 0.00 | 0.00 |
*All figures in crores except per share values
Sotac Pharmaceuticals Quick Links
Sotac Pharmaceuticals Dividend Sotac Pharmaceuticals Bonus Sotac Pharmaceuticals News Sotac Pharmaceuticals AGM Sotac Pharmaceuticals Rights Sotac Pharmaceuticals Splits Sotac Pharmaceuticals Board Meetings Sotac Pharmaceuticals Key Metrics Sotac Pharmaceuticals Shareholdings Sotac Pharmaceuticals Profit Loss Sotac Pharmaceuticals Cashflow Sotac Pharmaceuticals Q1 Results Sotac Pharmaceuticals Q2 Results Sotac Pharmaceuticals Q3 Results Sotac Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
359.35+14.15(4.10%)
245.05+8.85(3.75%)
4,077.55+123.65(3.13%)
1,340.70-9.85 (-0.73%)
1,868.00-2.40 (-0.13%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.